Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
about
Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activityMarked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseThe subunit structure and dynamics of the 20S proteasome in chicken skeletal muscle.Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma.Major histocompatibility complex class I-restricted antigen processing and presentation.Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages.Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma.Hepatitis C virus mutation affects proteasomal epitope processingUse of proteomics to define targets of T-cell immunity.Chronically active: activation of microglial proteolysis in ageing and neurodegeneration.Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.Inhibiting the immunoproteasome exacerbates the pathogenesis of systemic Candida albicans infection in mice.Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes.Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.Cytokines in cancer immunotherapy.Natural polyphenols as proteasome modulators and their role as anti-cancer compounds.Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.Dual biological effects of the cytokines interleukin-10 and interferon-γ.Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 AxisLipid A-mediated tolerance and cancer therapy.Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: A potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesis.TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.Global proteome analysis identifies active immunoproteasome subunits in human platelets.Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites.Subunit topology of two 20S proteasomes from Haloferax volcanii.Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo.Antigen-specific naive CD8+ T cells produce a single pulse of IFN-γ in vivo within hours of infection, but without antiviral effect.Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditisThe proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice.Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress.Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo.Epstein-Barr virus lytic cycle activation alters proteasome subunit expression in Burkitt's lymphoma cells.
P2860
Q24300867-D0CB1F89-E50A-4504-8178-65424579EFEFQ24815128-D0FAE450-204E-450F-BAD9-2AD42F780608Q28238379-C350CDD4-527E-4A9A-97D7-E080DDF43CC8Q33217414-7A0560EC-8FE6-4EAD-B301-F92B04462694Q33322191-01E7B0F5-6229-454A-BF50-8BED367B6B1FQ33897820-5959BAA9-857A-4ED6-BA32-EBF61C8E27AEQ34700785-3BD14267-7329-40DB-938D-9317FD0D5A85Q34941852-9FD92678-B80D-4D5E-BEAE-1C5C39284D6CQ35530297-7403823E-2728-40BE-9449-4AE8F6083FF2Q35539348-55C32007-262E-4BF2-9FF2-4CC51A876F90Q35731556-59782A6F-488E-4485-95FA-17E83BF5D5BAQ35835376-203F3FB3-34A7-4279-A28E-2DE6C6C0B03CQ36184807-D1403628-4738-4FA2-B719-F0CFBFD340EBQ36301730-4E85306F-2B19-477C-82F0-DE3EDFC92DFEQ36354644-5DEB62DA-6404-4BFF-96C3-277C2163E226Q36500101-362610EF-FB41-43CB-ACE9-6FA9A558975DQ36922697-86E0D82E-B330-4802-95CA-18C1E913FF14Q36960167-52340CD3-280F-4C7A-B2F3-8CFD7BAA3350Q36984148-8307634C-C519-46B8-9C9D-5BD588A950D6Q37051853-EB85DC42-5A69-4230-9D21-5E23C7D55E0BQ37148152-0F378D74-8FAB-4FFE-8297-F4BD3EDBE8F0Q37311396-26257A07-7B61-46BF-A0AD-9E6CDC752C65Q37610453-A5AC52B8-E521-48D5-A93C-293E1C57D16DQ37932437-E333932C-BF1F-4946-AAE0-A00D4DFE6DDBQ38002856-B70520E1-1FA5-4ECB-BF3E-E61BAE05756FQ38496963-67AB769B-FAAE-4AF5-9D7A-204AA9B27AE1Q38764320-702992BC-3E25-4E88-9458-5211FFA95BDCQ38830698-71A85C02-CEAF-434E-9959-560C01C75741Q38963810-903BC8C0-2BE6-4740-9630-6087F1277BA7Q39320211-5B8249E2-B374-4D1E-8FC6-BEA5F0CFE1F3Q39566694-BB905746-30A4-4D46-B8C4-FE12E1132342Q39702656-F02EC14F-2648-42FB-8AB4-1E175FBF46EBQ39869933-88BE6C39-89BA-4869-9DB6-A8D87780A51DQ40562140-2E3871C0-DA57-47CC-8161-453FF30A6028Q41889400-7648B684-DA17-43FF-BE80-8B3AD9E3AC36Q42109729-1811032A-F31F-4266-8385-772ACA04059EQ42738022-759C5BF4-EB02-47B0-8E06-526B76567D2DQ44495019-5CE0C8C8-6BF6-4A1D-B29E-DBE695140BF5Q44613323-E41A920B-5CAE-4118-B6E7-1AC7945D7D91Q45375411-F4140914-4D90-4232-95F6-05647DCBFB3B
P2860
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@ast
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@en
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@nl
type
label
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@ast
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@en
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@nl
prefLabel
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@ast
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@en
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@nl
P2093
P1433
P1476
Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
@en
P2093
P304
P356
10.1016/S0300-9084(01)01251-2
P577
2001-03-01T00:00:00Z